1996
DOI: 10.3892/ijo.9.6.1207
|View full text |Cite
|
Sign up to set email alerts
|

Expression of E-cadherin in 230 infiltrating ductal breast carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
15
0

Year Published

1996
1996
2003
2003

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(16 citation statements)
references
References 0 publications
1
15
0
Order By: Relevance
“…Since no mutations in the E-cadherin gene have been detected in tumours in the breast of the ductal histological type (Berx et al, 1996), this provides the clearest evidence of molecular difference in the two main histological types of breast carcinomas. Nonetheless, reduced expression of E-cadherin has been found in both lobular and ductal breast cancers (Oka et al, 1993;Gamallo et al, 1996) and detection of chromosome 16q22.1 is the highest documental loss of a chromosome region in sporadic breast cancers of both histological types (Skirnisdottir et al, 1995; this study). Two explanations of this difference are possible, either: (1) a gene other than the E-cadherin gene is the target of the 16q22.1 deletion in ductal compared to lobular carcinomas of breast cancer; or (2) the progression of ductal carcinomas is more sensitive to loss of one copy of the E-cadherin gene, and corresponding reduction of expression, than lobular breast carcinomas, where both copies need to be eliminated for further progression to malignant invasive growth.…”
Section: Discussionmentioning
confidence: 51%
“…Since no mutations in the E-cadherin gene have been detected in tumours in the breast of the ductal histological type (Berx et al, 1996), this provides the clearest evidence of molecular difference in the two main histological types of breast carcinomas. Nonetheless, reduced expression of E-cadherin has been found in both lobular and ductal breast cancers (Oka et al, 1993;Gamallo et al, 1996) and detection of chromosome 16q22.1 is the highest documental loss of a chromosome region in sporadic breast cancers of both histological types (Skirnisdottir et al, 1995; this study). Two explanations of this difference are possible, either: (1) a gene other than the E-cadherin gene is the target of the 16q22.1 deletion in ductal compared to lobular carcinomas of breast cancer; or (2) the progression of ductal carcinomas is more sensitive to loss of one copy of the E-cadherin gene, and corresponding reduction of expression, than lobular breast carcinomas, where both copies need to be eliminated for further progression to malignant invasive growth.…”
Section: Discussionmentioning
confidence: 51%
“…Dynamic expression is supported by the frequently observed re-expression of E-cadherin in secondary metastatic foci and even in some lymph node metastasis (Takeichi, 1993;Gamallo et al, 1996;Christofori and Semb, 1999;Graff et al, 2000). Dynamic regulation of E-cadherin expression is a tightly regulated process during embryonic development in which Ecadherin is lost when EMTs occur but is re-expressed in the reverse situation: the establishment of epithelial lineages from mesoderm layers (Takeichi, 1995;Huber et al, 1996).…”
Section: Discussionmentioning
confidence: 99%
“…It is well known that a HCC tumor subtypes. As no significant E-CD or catenin immunostaining often consists of multiple histological types 21 ; therefore, the heterogeneity was seen in any histological tumor lesion, the 41 HCCs were classified into the following 67 histologically composite score, which has recently been adopted for precise defined tumor lesions: 29 thin trabecular (TnT)-, 14 pseudo-evaluation of E-CD immunostaining, 25 was not used in the glandular (PG)-, 23 thick trabecular (TkT)-, and 1 compact-current study. type, according to the World Health Organization.…”
Section: Methodsmentioning
confidence: 99%